Immunohistochemical characterization of cyclin E and p27KIP1 expression in early hydatidiform moles

International Journal of Gynecological Pathology

Volumn 23, Issue 3, 2004, Pages 259-264

  Fukunaga, Masaharu ^a,b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin E; Hydatidiform mole; Immunohistochemistry; P27KIP1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; MONOCLONAL ANTIBODY; PROTEIN P27; UNCLASSIFIED DRUG;

ARTICLE; CYTOTROPHOBLAST; EARLY DIAGNOSIS; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; INDUCED ABORTION; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

ADOLESCENT; ADULT; CELL CYCLE PROTEINS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PLOIDIES; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TUMOR SUPPRESSOR PROTEINS; UTERINE NEOPLASMS;

EID: 3042702523     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000130447.22788.3b     Document Type: Article

References (19)

1. Bamberger AM, Sudahl S, Bamberger CM, et al. Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: implications for the control of proliferation. Placenta 1999;20:401-6.
2. Bamberger AM, Reithdorf L, Milde-Langosch K, et al. Strongly reduced expression of the cell cycle inhibitor p27 in endometrial hyperplasia and carcinoma. Virchows Arch 1999;434:423-8.
3. Chetty R. Cyclin E and p27/Kip1 two proteins on a see-saw or another false dawn? Histopathology 2002;40:393-4.
4. kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1997;154:313-20.
5. Fukunaga M. Immunohistochemical characterization of p57KIP2 expression in early hydatidiform moles. Hum Pathol 2002;33: 1188-92.
6. Szulman AE, Surti U. The syndrome of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-71.
7. Hedley DW, Freidlander M, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histocheme Cytochem 1983;31: 1333-5.
8. Fukunaga M, Ushigome S, Fukunaga M, et al. Application of cytometry in diagnosis of hydatidiform moles. Mod Pathol 1993; 6:353-9.
9. Fukunaga M. Histopathologic study of partial hydatidiform moles and DNA triploid placentas. Pathol Int 1994;44:528-34.
10. Olvera M, Harris S, Amezcua CA, et al. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, cyclin E, p27 kip1, and Ki-67 in normal placenta and gestational trophoblastic disease. Mod Pathol 2001;14:1036-42.
11. Kim YT, Cho NH, Ko JH, et al. H. Expression of cyclin E in placentas with hydropic changes and gestational trophoblastic diseases. Implications for the malignant transformation of trophoblasts. Cancer 2000;89:673-9.
12. DeLoia JA, Burlingame JM, Krasnow JS. Differential expression of GI cyclins during human placentognesis. Placenta 1997;18: 9-16.
13. Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J 1999;13:773-80.
14. Lonardo F, Rusch V, Langenfeld J, et al. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 1999;59: 2470-6.
15. Quade BJ, Park JJ, Crumb CP, et al. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11: 1238-46.
16. Wang G, Wang S, Wang J. Expression of CDKIp27Kip1 in trophoblastic neoplasm. Chin Med J 2000;113:1046-8.
17. Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased level of the cell cycle inhibitor p27/KIP1 protein: prognostic implications in primary breast cancer. Nature Med 1997;3:227-30.
18. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal cancers. Nature Med 1997;3:231-4.
19. Mori M, Mimori K, Shiraishi T, et al. p27 expression and gastric carcinoma. Nature Med 1997;3:593. (Letter)